| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | D0P25S3P81 |
| InChI Key | MXYUKLILVYORSK-HBMCJLEFSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H27NO2 |
| Molecular Weight | 337.46 |
| AlogP | 4.24 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 40.54 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 25.0 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Attention Deficit Disorder with Hyperactivity | 2 | D001289 | ClinicalTrials |
| Amphetamine-Related Disorders | 1 | D019969 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 90-69-7 |
| ChEBI | 48723 |
| ChEMBL | CHEMBL122270 |
| DrugBank | DB05137 |
| EPA CompTox | DTXSID3023219 |
| FDA SRS | D0P25S3P81 |
| KEGG | C07475 |
| PDB | L0B |
| PubChem | 101616 |
| SureChEMBL | SCHEMBL290803 |
| ZINC | ZINC000000001624 |